Evaluation of Intermittent Triple Therapies in Real Life.

A clinical trial, NCT06578702, is being conducted at the University Hospital in Strasbourg, France to evaluate the effectiveness and safety of intermittent triple therapy for people living with HIV. This strategy has been validated in France through a randomized clinical trial called QUATUOR, but there is limited real-life data and it is not recommended internationally. The trial aims to improve knowledge on the efficacy and tolerance of this therapeutic strategy. The trial is currently recruiting participants and is expected to be completed by February 2025. [Extracted from the article]